NASDAQ · Key Statistics

Mersana Therapeutics, Inc. (MRSN) Key Statistics

$29.08 NASDAQ: MRSN Market Cap $145.36M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Mersana Therapeutics, Inc. (MRSN), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-2.59
P/B ratioShare price divided by book value per share.	-2.44
P/S ratioMarket value divided by annual revenue.	8.64
PEG ratioP/E divided by the earnings growth rate.	-0.35
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-1.71
EV / RevenueEnterprise value against annual revenue.	5.43
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-38.61%
Free cash flow yieldFree cash flow as a percentage of market value.	-37.92%
Price / free cash flowMarket value divided by free cash flow.	-2.64

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	98.29%
Operating marginRevenue left after operating costs.	-312.53%
Net marginRevenue left after every cost, including tax and interest.	-332.74%
Return on equityProfit as a percentage of shareholders’ equity.	116.96%
Return on assetsProfit as a percentage of total assets.	-89.28%
Return on capital employedOperating profit against the capital the business uses.	-270.72%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	1.39
Quick ratioThe same, excluding inventory.	1.39
Cash ratioCash alone against current liabilities.	1.74
Debt to equityTotal borrowings against shareholders’ equity.	-0.04
Debt to assetsTotal borrowings against total assets.	0.20
Interest coverageHow many times operating profit covers the interest bill.	-28.52

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-14.12
Book value per shareShareholders’ equity divided by shares outstanding.	$-11.94
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$145.36M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$66.36M

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Mersana Therapeutics, Inc. (MRSN) statistics — frequently asked questions

What is Mersana Therapeutics, Inc.'s P/E ratio?

Mersana Therapeutics, Inc. (MRSN) trades on a price-to-earnings ratio of -2.59. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Mersana Therapeutics, Inc.'s return on equity?

Mersana Therapeutics, Inc. (MRSN) reports a return on equity of 116.96%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Mersana Therapeutics, Inc. carry?

Mersana Therapeutics, Inc. (MRSN) has a debt-to-equity ratio of -0.04, which compares total borrowings with shareholders' equity.

What is Mersana Therapeutics, Inc.'s profit margin?

Mersana Therapeutics, Inc. (MRSN) keeps -332.74% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.